ABTSC-DC vaccine (Cellonis Biotechnologies)

N/A

Report date: 2024/12/11 10:09:26

Base Information

Drug NameABTSC-DC vaccine (Cellonis Biotechnologies)

Drug Alias NameABTSC-DCdendritic cell vaccine containing autologous brain tumor stem cell antigens

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaPending

Originator CompaniesBeijing Cellonis Biotechnology Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBeijing Cellonis Biotechnology Corp

Active IndicationsN/A

Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A